Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Reckitt Benckiser Healthcare (UK) Ltd, Slough, SL1 4AQ
Lanacane Creme.
| Pharmaceutical Form |
|---|
|
Emulsion creme in an aluminium tube. |
| Active Ingredient | % | Specification |
|---|---|---|
| Benzocaine | 3.0 | E.P. |
Excipients with known effect:
Fragrances containing allergens (citronellol, benzyl benzoate, geraniol, benzyl alcohol, citral, cinnamal, alcohol, linalool and d-limonene) 0.064% w/w
Sulphonated castor oil 2.015% w/w
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Benzocaine |
Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited. |
| List of Excipients |
|---|
|
Chlorothymol |
In 30 gram and 60 gram aluminium tubes with a membrane covered nozzle and white high density polyethylene cap, overpacked in a printed folding cardboard unit carton.
Reckitt Benckiser Healthcare (UK) Ltd, Slough, SL1 4AQ
PL 00063/0671
26th April 1990 / 23rd July 1996
| Drug | Countries | |
|---|---|---|
| LANACANE | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
